Topics

Gilead Backs Down on Special Designation for Possible COVID-19 Drug

15:00 EDT 26 Mar 2020 | Drugs.com

THURSDAY, March 26, 2020 -- Following severe criticism, Gilead Sciences is backing off special designation of its antiviral drug remdesivir -- which shows promise against COVID-19 -- that would have allowed the company to block competition and...

Original Article: Gilead Backs Down on Special Designation for Possible COVID-19 Drug

NEXT ARTICLE

More From BioPortfolio on "Gilead Backs Down on Special Designation for Possible COVID-19 Drug"

Quick Search

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...